Cargando…
Clinical Potentials of Methylator Phenotype in Stage 4 High-Risk Neuroblastoma: An Open Challenge
Approximately 20% of stage 4 high-risk neuroblastoma patients are alive and disease-free 5 years after disease onset while the remaining experience rapid and fatal progression. Numerous findings underline the prognostic role of methylation of defined target genes in neuroblastoma without taking into...
Autores principales: | Banelli, Barbara, Merlo, Domenico Franco, Allemanni, Giorgio, Forlani, Alessandra, Romani, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661569/ https://www.ncbi.nlm.nih.gov/pubmed/23717404 http://dx.doi.org/10.1371/journal.pone.0063253 |
Ejemplares similares
-
MicroRNA in Glioblastoma: An Overview
por: Banelli, Barbara, et al.
Publicado: (2017) -
Inflammation, HIF-1, and the Epigenetics That Follows
por: Brigati, Claudio, et al.
Publicado: (2010) -
Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells
por: Banelli, Barbara, et al.
Publicado: (2017) -
Toward an Epigenetic View of Our Musical Mind
por: Brigati, Claudio, et al.
Publicado: (2012) -
Targeting of Histone Demethylases KDM5A and KDM6B Inhibits the Proliferation of Temozolomide-Resistant Glioblastoma Cells
por: Romani, Massimo, et al.
Publicado: (2019)